The Phase 2 1 mg arm is the strongest microdose evidence in the GLP-1 class direct measurement, not extrapolation
The objective of this study was to determine whether these NEXT GENERATION (NGEN) HepQuant Tests, using Risk ACE as endpoint, could detect treatment effects in MAESTRO-NAFLD-1 (NCT04197479), an open label, single arm study of resmetirom, a thyroid hormone receptor- agonist being studied for the treatment of NASH (Harrison et al., Lancet 2019, 394:2012-24)
The right choice in the Cagrilintide vs Retatrutide conversation depends on your individual health profile, tolerance for side effects, and what your doctor recommends
Can I use both together
Methods Production of CydDC from E
Your liver makes L- glutathione but it may be necessary to add additional glutathione to your diet in order to feel better